What Are the Pros and Cons of Immunotherapy? - WebMD Immunotherapy for cancer works in two ways Some drugs can stimulate the immune system to work more aggressively at identifying and fighting cancer cells Other drugs, synthetic versions of
Cancer immunotherapy | Nature Reviews Clinical Oncology Read the latest Research articles in Cancer immunotherapy from Nature Reviews Clinical Oncology bacteria can have crucial roles in both the pathogenesis and treatment of cancer In this Review
A review of cancer immunotherapy: from the past, to the . . . Immunotherapy has now firmly established itself as a novel pillar of cancer care, from the metastatic stage to the adjuvant and neoadjuvant settings in numerous cancer types In this review article, we highlight how the history of cancer immunotherapy paved the way for discoveries that are now part of the standard of care
Innovations in cancer immunotherapy: A comprehensive overview . . . This review aims to provide an overview of current immunotherapy applications in cancer treatment It summarizes the various types of immunotherapies, ongoing and successful clinical trials, emerging trends, and research developments, as well as the challenges faced in this field
Immunotherapy in the Treatment of Cancer: Today and Tomorrow Purpose of Review This review aims to synthesize the latest advances in immunotherapeutic cancer treatment approaches and spotlight groundbreaking discoveries and clinical trial outcomes Recent Findings Immunotherapy represents a promising and transformative strategy for treating a variety of hematological malignancies and solid tumors This therapeutic approach strives to bolster the body's
Cancer immunotherapies: advances and bottlenecks - PubMed Several cancer immunotherapies, include immune checkpoint inhibitors (ICIs), cancer vaccine, adoptive cell transfer (ACT), have shown great efficacy and promise In this review, we will summarize the recent research advances in tumor immunotherapy, including the molecular mechanisms and clinical effects as well as limitations of immunotherapy
Clinical cancer immunotherapy: Current progress and prospects We discuss limitations, immune resistance, and combination strategies in this review and hope to give a promising outlook for the future development of cancer immunotherapy FIGURE 1 Figure 1 Cancer immunotherapy methods, including monoclonal antibodies (mAbs), small molecule drugs, adoptive cell therapy, oncolytic virus, and cancer vaccines
A Review on Cancer Immunotherapy and Applications of . . . In this review, cancer immunotherapy is explained, and the clinical applications are detailed In addition, the role and privileges of immunochemotherapy and nanoparticulate delivery systems in immunotherapy are summarized in the light of preclinical studies and recent literature 2 The Immune System and Its Role in Cancer Immunotherapy
Cancer Research Institute Publishes Inaugural 2025 Cancer . . . New York, NY — The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing immune-based treatments for cancer, has released its inaugural 2025 Cancer Immunotherapy Insights and Impact report—an authoritative, data-driven review of the evolution of cancer immunotherapy over the past decade along with an in-depth look
Current advances in immunotherapy for cancer - ScienceDirect This review outlines recent progress in cancer immunotherapy, with a focus on checkpoint inhibitors and CAR-T cell therapy It discusses clinical successes, ongoing challenges, and future research directions Over the last decade, a number of immunotherapeutic agents have become standard in cancer treatment
Top cancer centers set sights on immunotherapy innovation Duarte, Calif -based City of Hope has been awarded a contract of up to $23 7 million to study how advanced or metastatic non-small cell lung cancer tumors change during immunotherapy treatment